Journal
Frontiers in Immunology
Publication Date
1-1-2022
Volume
13
First Page
1039226
Document Type
Open Access Publication
DOI
10.3389/fimmu.2022.1039226
Rights and Permissions
Peng H, Li L, Zuo C, Chen MY, Zhang X, Myers NB, Hogg GD, DeNardo DG, Goedegebuure SP, Hawkins WG and Gillanders WE (2022) Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer. Front. Immunol. 13:1039226. doi: 10.3389/fimmu.2022.1039226 © 2022 Peng, Li, Zuo, Chen, Zhang, Myers, Hogg, DeNardo, Goedegebuure, Hawkins and Gillanders. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
Recommended Citation
Peng, Hui; Li, Lijin; Zuo, Chong; Chen, Michael Y; Zhang, Xiuli; Myers, Nancy B; Hogg, Graham D; DeNardo, David G; Goedegebuure, S Peter; Hawkins, William G; and Gillanders, William E, "Combination TIGIT/PD-1 blockade enhances the efficacy of neoantigen vaccines in a model of pancreatic cancer." Frontiers in Immunology. 13, 1039226 (2022).
https://digitalcommons.wustl.edu/oa_4/2442
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
